GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 16.16 | 4.88 | 4.43 | 14.19 | 15.30 |
What is the latest Return on Capital Employed (ROCE) ratio of GLENMARK PHARMACEUTICALS ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 16.16 |
| Mar2024 | 4.88 |
| Mar2023 | 4.43 |
| Mar2022 | 14.19 |
| Mar2021 | 15.30 |
How is Return on Capital Employed (ROCE) of GLENMARK PHARMACEUTICALS Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 16.16 | 231.15 | |
| Mar2024 | 4.88 | 10.16 | |
| Mar2023 | 4.43 | -68.78 | |
| Mar2022 | 14.19 | -7.25 | |
| Mar2021 | 15.3 | - | |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹59,925.2 Cr | 3% | 9.5% | 61.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3% |
9.5% |
61.3% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses